Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome

被引：15
作者：
Szejko, Natalia [1 ,2 ,3 ]
Saramak, Kamila [2 ]
Lombroso, Adam [4 ]
Mueller-Vahl, Kirsten R. [5 ]
机构：
[1] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[2] Med Univ Warsaw, Dept Bioeth, Warsaw, Poland
[3] Yale Univ, Dept Neurol, New Haven, CT USA
[4] Yale Sch Med, Ctr Child Study, New Haven, CT USA
[5] Hannover Med Sch, Psychiat Clin Social Psychiat & Psychotherapy, Hannover, Germany
来源：
NEUROLOGIA I NEUROCHIRURGIA POLSKA | 2022年 / 56卷 / 01期
关键词：
Gilles de la Tourette syndrome; tics; cannabis-based medicine; THC; dronabinol; tetrahydrocannabinol; obsessive--compulsivedisorder; attention deficit; hyperactivity disorder; EUROPEAN CLINICAL GUIDELINES; DELTA(9)-TETRAHYDROCANNABINOL THC; SCALE; TICS; RECEPTOR; CHILDREN; THERAPY;
D O I：
10.5603/PJNNS.a2021.0081
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：28 / 38
页数：11
相关论文
共 61 条
[1]   Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With Tourette Syndrome [J].
Abi-Jaoude, Elia ;
Chen, Lei ;
Cheung, Patrina ;
Bhikram, Tracy ;
Sandor, Paul .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2017, 29 (04) :391-400
[2]  
[Anonymous], 1988, Tourette's Syndrome and Tic Disorders
[3]   TRPV1: Structure, Endogenous Agonists, and Mechanisms [J].
Benitez-Angeles, Miguel ;
Luz Morales-Lazaro, Sara ;
Juarez-Gonzalez, Emmanuel ;
Rosenbaum, Tamara .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
[4]   [123 I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Δ9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in Tourette patients [J].
Berding, G ;
Müller-Vahl, K ;
Schneider, U ;
Gielow, P ;
Fitschen, J ;
Stuhrmann, M ;
Harke, H ;
Buchert, R ;
Donnerstag, F ;
Hofmann, M ;
Knoop, BO ;
Brooks, DJ ;
Emrich, HM ;
Knapp, WH .
BIOLOGICAL PSYCHIATRY, 2004, 55 (09) :904-915
[5]   Novel cannabinoid receptors [J].
Brown, A. J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (05) :567-575
[6]   Cannabinoids improve driving ability in a Tourette's patient [J].
Brunnauer, Alexander ;
Segmiller, Felix Maximilian ;
Volkamer, Thomas ;
Laux, Gerd ;
Mueller, Norbert ;
Dehning, Sandra .
PSYCHIATRY RESEARCH, 2011, 190 (2-3) :382-382
[7]   The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL) Development and validation [J].
Cavanna, A. E. ;
Schrag, A. ;
Morley, D. ;
Orth, M. ;
Robertson, M. M. ;
Joyce, E. ;
Critchley, H. D. ;
Selai, C. .
NEUROLOGY, 2008, 71 (18) :1410-1416
[8]   Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis [J].
Collin, C. ;
Davies, P. ;
Mutiboko, I. K. ;
Ratcliffe, S. .
EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (03) :290-296
[9]   The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra [J].
Davis, Margaret I. ;
Crittenden, Jill R. ;
Feng, Austin Y. ;
Kupferschmidt, David A. ;
Naydenov, Alipi ;
Stella, Nephi ;
Graybiel, Ann M. ;
Lovinger, David M. .
PLOS ONE, 2018, 13 (02)
[10]   Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene [J].
Gadzicki, D ;
Müller-Vahl, KR ;
Heller, D ;
Ossege, S ;
Nöthen, MM ;
Hebebrand, J ;
Stuhrmann, M .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 127B (01) :97-103
1234567